Physician profile
Jose Arencibia
NPI 1841264249
$2,579.41
in general payments reported to CMS, 2019-2025
18 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $113 · 2021: $346 · 2022: $570 · 2023: $442 · 2024: $614 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314 · Entertainment: $18.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.41 |
| Entertainment | $18.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $493.51 | 2022-2025 | Infuse, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $483.48 | 2019-2023 | Cequa |
| Abbvie INC. | $237.27 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Visioneering Technologies, INC. | $197.09 | 2023-2024 | |
| Alcon Vision LLC | $178.87 | 2019-2025 | Rocklatan, Total30, Precision7 |
| Lombart Brothers, INC. | $140.28 | 2021-2022 | |
| Allergan, INC. | $136.33 | 2020-2022 | |
| Glaukos Corporation | $131.13 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Oyster Point Pharma, INC. | $101.30 | 2022 | |
| Rxsight INC | $100.00 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece |
| Dompe US, INC. | $89.10 | 2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $84.54 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.41 | 2019-2020 | |
| Biotissue Holdings INC. | $52.76 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $38.92 | 2024-2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $18.84 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $14.19 | 2019 | |
| Carl Zeiss Meditec, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Arencibia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.